Clinical Trial Update: Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hyperfractionated radiotherapy with BCNU to conventional radiotherapy with BCNU in supratentorial malignant glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioblastoma Multiforme
• Glioma

Drugs mentioned

• BCNU (carmustine)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Glioma, Glioblastoma Multiforme | Phase 3 | Status: COMPLETED